Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis
Clinical trial NCT01094093 · COMPLETED
Trial details
- NCT number
- NCT01094093
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-11
- Primary completion
- 2011-07-26
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.